These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3251423)

  • 21. [Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].
    Izumi M
    Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):27-32. PubMed ID: 8437550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peripheral lymphocyte subset analysis by monoclonal antibodies in patients with malignant lymphoma].
    Takada K; Morishita M; Yamamoto M; Oyama A; Amano Y; Kato R; Oguri T
    Rinsho Byori; 1984 Jun; 32(6):646-50. PubMed ID: 6492419
    [No Abstract]   [Full Text] [Related]  

  • 23. [Flow-cytometric analysis of changes in lymphocyte subsets in the blood of cancer patients during radiotherapy. 9. Special reference to head and neck cancer patients].
    Ogawa Y; Maeda T; Hamada F; Sawada A; Morita M; Yamamoto Y; Yoshida S; Saito H; Ono A; Ozaki T
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2279-85. PubMed ID: 3831172
    [No Abstract]   [Full Text] [Related]  

  • 24. [Subsets of peripheral blood lymphocytes and thymic lymphoid cells in myasthenia gravis. Analysis by fluorocytometry with monoclonal antibodies].
    Machi M
    Fukuoka Igaku Zasshi; 1986 May; 77(5):241-52. PubMed ID: 3488945
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K
    Anticancer Res; 1995; 15(3):799-804. PubMed ID: 7645961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preoperative determination of CEA and GICA in gastric neoplasms].
    Sanlorenzo M; Caldarola F; Vigezzi P; Rocca N; Pecchio F
    Minerva Med; 1989 Mar; 80(3):255-9. PubMed ID: 2717045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro labelling of epithelial tumor cells with anti 17-1A monoclonal antibodies in bone marrow of cancer patients.
    Schlimok G; Göttlinger H; Funke I; Swierkot S; Häuser H; Riethmüller G
    Hybridoma; 1986 Jul; 5 Suppl 1():S163-70. PubMed ID: 3744380
    [No Abstract]   [Full Text] [Related]  

  • 28. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
    Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
    Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical study of spleens in gastric cancer].
    Hiramatsu S
    Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1591-603. PubMed ID: 3501536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunologic indicators in patients with stomach cancer at various clinical stages].
    Moszczyński P; Sułowicz W
    Przegl Lek; 1986; 43(9):606-9. PubMed ID: 3809569
    [No Abstract]   [Full Text] [Related]  

  • 31. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
    Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
    Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cellular immunity in patients with esophageal and gastric tumors in various stages].
    Horváth OP; Petri I; Kaiser G; Imre J; Petri G
    Orv Hetil; 1981 Jun; 122(26):1567-72. PubMed ID: 7290665
    [No Abstract]   [Full Text] [Related]  

  • 34. [ Tissue and blood CEA levels in stomach cancer].
    Palmeri R; Rizzo AG; Cuffari B; Lo Forti B; Di Pietro N; Gorgone S; Sampiero G; Barbuscia M; Dattola P
    Minerva Chir; 1993 Feb; 48(3-4):153-6. PubMed ID: 8479651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quantitative variations of lymphocyte subsets in various kinds of cancer patients in the terminal stage].
    Nakajima Y; Akimoto M; Iwasaki H; Matano S; Hirakawa H; Kimura M
    Gan No Rinsho; 1986 Dec; 32(15):1925-8. PubMed ID: 3806964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymphocyte count in the blood of stomach cancer patients].
    Volodarskiĭ VL; Maslova MG; Gurina LI; Dybova TV
    Vestn Khir Im I I Grek; 1981 Feb; 126(2):23-7. PubMed ID: 6972117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of hemodialysis on lymphocyte subsets during dialysis.
    Chida Y; Sakurai S; Yoshiyama N
    Clin Nephrol; 1986 Mar; 25(3):159-64. PubMed ID: 3754188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The alternation of peripheral lymphocyte subsets in head and neck carcinoma].
    Mitarai K; Tsukuda M; Mochimatsu I; Kubota A; Sawaki S
    Gan No Rinsho; 1986 Jul; 32(8):849-54. PubMed ID: 3747146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum anti-p53 antibodies in gastric cancer patients].
    Lawniczak M; Bielicki D; Sulzyc-Bielicka V; Marlicz K; Starzyńska T
    Pol Merkur Lekarski; 2007 Sep; 23(135):192-5. PubMed ID: 18080693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
    Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.